Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 22025D1036

Decision of the EEA Joint Committee No 45/2025 of 14 March 2025 amending Annex I (Veterinary and phytosanitary matters) and Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/1036]

OJ L, 2025/1036, 12.6.2025, ELI: http://data.europa.eu/eli/dec/2025/1036/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Legal status of the document In force

ELI: http://data.europa.eu/eli/dec/2025/1036/oj

European flag

Official Journal
of the European Union

EN

L series


2025/1036

12.6.2025

DECISION OF THE EEA JOINT COMMITTEE No 45/2025

of 14 March 2025

amending Annex I (Veterinary and phytosanitary matters) and Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/1036]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1)

Commission Regulation (EU) 2024/2609 of 7 October 2024 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for napropamide, pyridaben and tebufenpyrad in or on certain products (1) is to be incorporated into the EEA Agreement.

(2)

Commission Regulation (EU) 2024/2612 of 7 October 2024 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for chitosan, clopyralid, difenoconazole, fat distillation residues, flonicamid, hydrolysed proteins, and lavandulyl senecioate in or on certain products (2) is to be incorporated into the EEA Agreement.

(3)

Commission Regulation (EU) 2024/2619 of 8 October 2024 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for fosetyl, potassium phosphonates and disodium phosphonate in or on certain products (3) is to be incorporated into the EEA Agreement.

(4)

Commission Regulation (EU) 2024/2633 of 8 October 2024 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, famoxadone, flutriafol, mandipropamid and mefentrifluconazole in or on certain products (4) is to be incorporated into the EEA Agreement.

(5)

Commission Regulation (EU) 2024/2640 of 9 October 2024 amending and correcting Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for 1,4-dimethylnaphthalene, difluoroacetic acid (DFA), fluopyram and flupyradifurone in or on certain products (5) is to be incorporated into the EEA Agreement.

(6)

This Decision concerns legislation regarding feedingstuffs and foodstuffs. Legislation regarding feedingstuffs and foodstuffs shall not apply to Liechtenstein as long as the application of the Agreement between the European Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein, as specified in the sectoral adaptations to Annex I and the introduction to Chapter XII of Annex II to the EEA Agreement. This Decision is therefore not to apply to Liechtenstein.

(7)

Annexes I and II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indents are added in point 40 (Regulation (EC) No 396/2005 of the European Parliament and of the Council) of Chapter II of Annex I to the EEA Agreement:

‘—

32024 R 2609: Commission Regulation (EU) 2024/2609 of 7 October 2024 (OJ L, 2024/2609, 8.10.2024),

32024 R 2612: Commission Regulation (EU) 2024/2612 of 7 October 2024 (OJ L, 2024/2612, 8.10.2024),

32024 R 2619: Commission Regulation (EU) 2024/2619 of 8 October 2024 (OJ L, 2024/2619, 9.10.2024),

32024 R 2633: Commission Regulation (EU) 2024/2633 of 8 October 2024 (OJ L, 2024/2633, 9.10.2024),

32024 R 2640: Commission Regulation (EU) 2024/2640 of 9 October 2024 (OJ L, 2024/2640, 10.10.2024).’

Article 2

The following indents are added in point 54zzy (Regulation (EC) No 396/2005 of the European Parliament and of the Council) of Chapter XII of Annex II to the EEA Agreement:

‘—

32024 R 2609: Commission Regulation (EU) 2024/2609 of 7 October 2024 (OJ L, 2024/2609, 8.10.2024),

32024 R 2612: Commission Regulation (EU) 2024/2612 of 7 October 2024 (OJ L, 2024/2612, 8.10.2024),

32024 R 2619: Commission Regulation (EU) 2024/2619 of 8 October 2024 (OJ L, 2024/2619, 9.10.2024),

32024 R 2633: Commission Regulation (EU) 2024/2633 of 8 October 2024 (OJ L, 2024/2633, 9.10.2024),

32024 R 2640: Commission Regulation (EU) 2024/2640 of 9 October 2024 (OJ L, 2024/2640, 10.10.2024).’

Article 3

The texts of Regulations (EU) 2024/2609, (EU) 2024/2612, (EU) 2024/2619, (EU) 2024/2633 and (EU) 2024/2640 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 4

This Decision shall enter into force on 15 March 2025, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 5

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 14 March 2025.

For the EEA Joint Committee

The President

Nicolas VON LINGEN


(1)   OJ L, 2024/2609, 8.10.2024, ELI: http://data.europa.eu/eli/reg/2024/2609/oj.

(2)   OJ L, 2024/2612, 8.10.2024, ELI: http://data.europa.eu/eli/reg/2024/2612/oj.

(3)   OJ L, 2024/2619, 9.10.2024, ELI: http://data.europa.eu/eli/reg/2024/2619/oj.

(4)   OJ L, 2024/2633, 9.10.2024, ELI: http://data.europa.eu/eli/reg/2024/2633/oj.

(5)   OJ L, 2024/2640, 10.10.2024, ELI: http://data.europa.eu/eli/reg/2024/2640/oj.

(*1)  No constitutional requirements indicated.


ELI: http://data.europa.eu/eli/dec/2025/1036/oj

ISSN 1977-0677 (electronic edition)


Top